{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:47:42Z","timestamp":1791920862048,"version":"4.3.4"},"reference-count":216,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305765\/2015-9"],"award-info":[{"award-number":["305765\/2015-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/202.894\/2017"],"award-info":[{"award-number":["E-26\/202.894\/2017"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Non-Hodgkin lymphoma is the most common malignancy affecting people living with HIV (PLWH). Among its several subtypes, diffuse large B-cell lymphoma (DLBCL) is an important manifestation within the HIV-infected compartment of the population. Since HIV is able to modulate B cells and promote lymphomagenesis through direct and indirect mechanisms, HIV-related DLBCL has specific characteristics. In this review, we address the clinical and molecular properties of DLBCL disease in the context of HIV infection, as well as the mechanisms by which HIV is able to modulate B lymphocytes and induce their transformation into lymphoma.<\/jats:p>","DOI":"10.3389\/fonc.2021.675353","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T08:51:32Z","timestamp":1619686292000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical and Molecular Properties of Human Immunodeficiency Virus-Related Diffuse Large B-Cell Lymphoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Pedro S.","family":"de Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio E.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo A.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2003.10.025","article-title":"The Hodgkin and Reed\/Sternberg Cell","volume":"37","author":"K\u00fcppers","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-07255-7.00038-6","article-title":"The Hodgkin and Reed\/Sternberg Cell","author":"Ehrlich","year":"2012"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.18295\/squmj.2015.15.03.003","article-title":"A Historical Tale of Two Lymphomas: Part Ii: Non-Hodgkin Lymphoma","volume":"15","author":"Lakhtakia","year":"2015","journal-title":"Sultan Qaboos Univ Med J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01988.x","article-title":"Historical Review of Lymphomas","volume":"109","author":"Aisenberg","year":"2000","journal-title":"Br J Haematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin Lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"key":"B6","article-title":"Non-Hodgkin lymphoma Globocan","year":"2020"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin Lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e987","DOI":"10.1097\/MD.0000000000000987","article-title":"Prevalence of Common non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement","volume":"94","author":"Laurent","year":"2015","journal-title":"Med (United States)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin\u2019s Lymphomas: Distributions of the Major Subtypes Differ by Geographic Locations","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.148809","article-title":"Non-Hodgkin Lymphoma in the Developing World: Review of 4539 Cases From the International non-Hodgkin Lymphoma Classification Project","volume":"101","author":"Perry","year":"2016","journal-title":"Haematologica"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canep.2014.12.001","article-title":"Racial Differences in Three Major NHL Subtypes: Descriptive Epidemiology","volume":"39","author":"Li","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"B13","unstructured":"Seer Cancer Stat Facts: Diffuse Large B-Cell Lymphoma"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2016.05.008","article-title":"The Burden of non-Hodgkin Lymphoma in Central and South America","volume":"44","author":"Diumenjo","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16489","article-title":"Trends in the Prevalence, Incidence and Survival of non-Hodgkin Lymphoma Subtypes During the 21st Century \u2013 a Swedish Lymphoma Register Study","volume":"189","author":"Ekberg S","year":"2020","journal-title":"Br J Haematol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.294","article-title":"Risk of Lymphoma Subtypes After Solid Organ Transplantation in the United States","volume":"109","author":"Clarke","year":"2013","journal-title":"Br J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00120-4","article-title":"Epidemiology of AIDS-related Tumours in Developed and Developing Countries","volume":"37","author":"Dal Maso","year":"2001","journal-title":"Eur J Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60047-5","article-title":"Spectrum of AIDS-associated Malignant Disorders","volume":"352","author":"Franceschi","year":"1998","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<645::AID-IJC6>3.0.CO;2-X","article-title":"Non-Hodgkin\u2019s Lymphoma Among People With Aids: Incidence, Presentation and Public Health Burden","volume":"73","author":"Cot\u00e9","year":"1997","journal-title":"Int J Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000163","article-title":"Epidemiologic Contributions to Recent Cancer Trends Among HIV-infected People in the United States","volume":"28","author":"Robbins","year":"2014","journal-title":"AIDS"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1462","article-title":"Incidence and Risk Factors of HIV-related non- Hodgkin\u2019s Lymphoma in the Era of Combination Antiretroviral Therapy: A European Multicohort Study","volume":"14","author":"Bohlius","year":"2009","journal-title":"Antivir Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/dju503","article-title":"Excess Cancers Among HIV-infected People in the United States","volume":"107","author":"Robbins","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1159\/000456036","article-title":"Hiv-Associated Malignant Lymphoma","volume":"40","author":"Brunnberg","year":"2017","journal-title":"Oncol Res Treat"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833a0961","article-title":"Survival of non-Hodgkin Lymphoma Patients With and Without Hiv Infection in the Era of Combined Antiretroviral Therapy","volume":"24","author":"Chao","year":"2010","journal-title":"AIDS"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000133","article-title":"Hiv Status Does Not Impair the Outcome of Patients Diagnosed With Diffuse Large B-Cell Lymphoma Treated With R-CHOP in the cART Era","volume":"28","author":"Coutinho","year":"2014","journal-title":"AIDS"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-498964","article-title":"Treatment Factors Affecting Outcomes in HIV-associated non-Hodgkin Lymphomas: A Pooled Analysis of 1546 Patients","volume":"122","author":"Barta","year":"2013","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2012.13.10.4889","article-title":"Primary Extra Nodal non Hodgkin Lymphoma: A 5 Year Retrospective Analysis","volume":"13","author":"Padhi","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.mpmed.2017.02.008","article-title":"Non-Hodgkin Lymphoma","volume":"45","author":"Ninkovic","year":"2017","journal-title":"Med (United Kingdom)"},{"key":"B29","article-title":"Report of the Committee on Hodgkin\u2019s Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.6.368","article-title":"Staging Non-Hodgkin Lymphoma","volume":"55","author":"Armitage","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402","article-title":"A Predictive Model for Aggressive Non-Hodgkin\u2019s Lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/35000501","article-title":"Distinct Types of Diffuse Large B-cell Lymphoma Identified by Gene Expression Profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12589","article-title":"The Molecular Pathogenesis of B-cell non-Hodgkin Lymphoma","volume":"95","author":"Blombery","year":"2015","journal-title":"Eur J Haematol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining Cell-of-Origin Subtypes of Diffuse Large B-cell Lymphoma Using Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue","volume":"123","author":"Scott","year":"2014","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers7020812","article-title":"Insights Into the Molecular Pathogenesis of Activated B-Cell-Like Diffuse Large B-cell Lymphoma and its Therapeutic Implications","volume":"7","author":"Lenz","year":"2015","journal-title":"Cancers (Basel)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040973","article-title":"Plasma Cell Ontogeny Defined by Quantitative Changes in Blimp-1 Expression","volume":"200","author":"Kallies","year":"2004","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","article-title":"Blimp-1 Orchestrates Plasma Cell Differentiation by Extinguishing the Mature B Cell Gene Expression Program","volume":"17","author":"Shaffer","year":"2002","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.10.030","article-title":"Blimp1 Is a Tumor Suppressor Gene Frequently Disrupted in Activated B Cell-Like Diffuse Large B Cell Lymphoma","volume":"18","author":"Mandelbaum","year":"2010","journal-title":"Cancer Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1732008100","article-title":"A Gene Expression-Based Method to Diagnose Clinically Distinct Subgroups of Diffuse Large B Cell Lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the Molecular Classification of Diffuse Large B-cell Lymphoma by Immunohistochemistry Using a Tissue Microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1867.1867","article-title":"Cell of Origin by Immunohistochemistry is Not Prognostic of Overall Survival in HIV Associated DLBCL- Analysis of Clinical Pathological Markers in HIV Dlbcl","volume":"128","author":"Nandikolla","year":"2016","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nri953","article-title":"Lymphoid Malignancies: The Dark Side of B-cell Differentiation","volume":"2","author":"Shaffer","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.biochem.76.061705.090740","article-title":"Molecular Mechanisms of Antibody Somatic Hypermutation","volume":"76","author":"Di Noia","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2013.04.006","article-title":"Erroneous Class Switching and False Vdj Recombination: Molecular Dissection of T(8;14)\/MYC-IGH Translocations Inburkitt-Type Lymphoblastic Leukemia\/B-Cell Lymphoma","volume":"7","author":"Burmeister","year":"2013","journal-title":"Mol Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-464958","article-title":"Bcl6 Breaks Occur At Different AID Sequence Motifs in Ig\u2013BCL6 and non-Ig\u2013BCL6 Rearrangements","volume":"121","author":"Lu","year":"2013","journal-title":"Blood"},{"key":"B46","article-title":"Molecular Anatomy of BCL6 Translocations Revealed by Long-Distance Polymerase Chain Reaction-Based Assays","volume":"60","author":"Akasaka","year":"2000","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/35085588","article-title":"Hypermutation of Multiple Proto-Oncogenes in B-cell Diffuse Large-Cell Lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1043\/1543-2165(2003)127<1148:CTIINL>2.0.CO;2","article-title":"Chromosomal Translocations Involved in non-Hodgkin Lymphomas","volume":"127","author":"Vega","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v96.3.808.015k30_808_822","article-title":"The Role of Immunoglobulin Translocations in the Pathogenesis of B-cell Malignancies","volume":"96","author":"Willis","year":"2000","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14011","article-title":"Molecular Genetics of Childhood, Adolescent and Young Adult non-Hodgkin Lymphoma","volume":"173","author":"Miles","year":"2016","journal-title":"Br J Haematol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.22.7166","article-title":"A 14;18 and an 8;14 Chromosome Translocation in a Cell Line Derived From an Acute B-Cell Leukemia","volume":"81","author":"Pegoraro","year":"1984","journal-title":"Proc Natl Acad Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63284-1","article-title":"Bcl2 Translocation Defines a Unique Tumor Subset Within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma","volume":"165","author":"Iqbal","year":"2004","journal-title":"Am J Pathol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.7.2285","article-title":"The T(14;18) Defines a Unique Subset of Diffuse Large B-cell Lymphoma With a Germinal Center B-cell Gene Expression Profile","volume":"99","author":"Huang","year":"2002","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0092-8674(85)80070-2","article-title":"Cloning the Chromosomal Breakpoint of T(14;18) Human Lymphomas: Clustering Around Jh on Chromosome 14 and Near a Transcriptional Unit on 18","volume":"41","author":"Bakhshi","year":"1985","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.066209","article-title":"Patients With Diffuse Large B-Cell Lymphoma of Germinal Center Origin With BCL2 Translocations Have Poor Outcome, Irrespective of MYC Status: A Report From an International Dlbcl Rituximab-CHOP Consortium Program Study","volume":"98","author":"Visco","year":"2013","journal-title":"Haematologica"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.11.5262","article-title":"Identification of the Gene Associated With the Recurring Chromosomal Translocations T(3;14)(q27;q32) and T(3;22)(q27;q11) in B-cell Lymphomas","volume":"90","author":"Baron","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404856","article-title":"Distinctive Patterns of BCL6 Molecular Alterations and Their Functional Consequences in Different Subgroups of Diffuse Large B-cell Lymphoma","volume":"21","author":"Iqbal","year":"2007","journal-title":"Leukemia"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv019","article-title":"Genetic Lesions in Diffuse Large B-cell Lymphomas","volume":"26","author":"Testoni","year":"2015","journal-title":"Ann Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(99)90141-7","article-title":"Bcl-6 and Bcl-2 Protein Expression in Diffuse Large B-cell Lymphoma and Follicular Lymphoma: Correlation With 3q27 and 18q21 Chromosomal Abnormalities","volume":"30","author":"Skinnider","year":"1999","journal-title":"Hum Pathol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.14670\/HH-19.637","article-title":"Pathogenetic Role of BCL6 Translocation in B-cell non-Hodgkin\u2019s Lymphoma","volume":"19","author":"Ohno","year":"2004","journal-title":"Histol Histopathol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204595","article-title":"Translocations Involving C-Myc and C-Myc Function","volume":"20","author":"Boxer","year":"2001","journal-title":"Oncogene"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.9.3152.421a07_3152_3162","article-title":"Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma","volume":"92","author":"Kramer","year":"1998","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.344","article-title":"Clinical Features and Prognosis of De Novo Diffuse Large B-cell Lymphoma With T(14;18) and 8q24\/c-MYC Translocations","volume":"23","author":"Niitsu","year":"2009","journal-title":"Leukemia"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-647602","article-title":"Myc-IG Rearrangements are Negative Predictors of Survival in DLBCL Patients Treated With Immunochemotherapy: A Gela\/Lysa Study","volume":"126","author":"Copie-Bergman","year":"2015","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08159.x","article-title":"Advances in the Understanding of MYC-induced Lymphomagenesis","volume":"149","author":"Klapproth","year":"2010","journal-title":"Br J Haematol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.blre.2016.09.004","article-title":"High Grade B-Cell Lymphoma With Rearrangements of MYC and BCL2 and\/or BCL6: Double Hit and Triple Hit Lymphomas and Double Expressing Lymphoma","volume":"31","author":"Rosenthal","year":"2017","journal-title":"Blood Rev"},{"key":"B67","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11864-015-0374-0","article-title":"Aggressive B Cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit Dlbcl","volume":"16","author":"Dunleavy","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-33230-3","article-title":"Mutation of TP53, Translocation Analysis and Immunohistochemical Expression of MYC, BCL-2 and BCL-6 in Patients With DLBCL Treated With R-Chop","volume":"8","author":"Peroja","year":"2018","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-671362","article-title":"MYC in DLBCL: Partners Matter","volume":"126","author":"Campo","year":"2015","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"B71","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1046\/j.1365-2443.1998.00223.x","article-title":"Role of Bcl-2 Family Proteins in Apoptosis: Apoptosomes or Mitochondria","volume":"3","author":"Tsujimoto","year":"1998","journal-title":"Genes Cells"},{"key":"B72","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri1944","article-title":"The CARMA1 Signalosome Links the Signalling Machinery of Adaptive and Innate Immunity in Lymphocytes","volume":"6","author":"Rawlings","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF03401664","article-title":"The CDKN2A (P16) Gene and Human Cancer","volume":"3","author":"Foulkes","year":"1997","journal-title":"Mol Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and Structural Analysis of Diffuse Large B-cell Lymphoma Using Whole-Genome Sequencing","volume":"122","author":"Mungall","year":"2013","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.668286","article-title":"Role of Nuclear Factor-\u03bab Regulators TNFAIP3 and CARD11 in Middle Eastern Diffuse Large B-cell Lymphoma","volume":"53","author":"Bu","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular Subtypes of Diffuse Large B-cell Lymphoma Arise by Distinct Genetic Pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI70626","article-title":"Germinal Center Dysregulation by Histone Methyltransferase EZH2 Promotes Lymphomagenesis","volume":"123","author":"Caganova","year":"2013","journal-title":"J Clin Invest"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/ng.518","article-title":"Somatic Mutations Altering EZH2 (Tyr641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal-Center Origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"B80","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1038\/s41467-018-06354-3","article-title":"Genome-Wide Discovery of Somatic Regulatory Variants in Diffuse Large B-cell Lymphoma","volume":"9","author":"Arthur","year":"2018","journal-title":"Nat Commun"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-321208","article-title":"Somatic Mutations At EZH2 Y641 Act Dominantly Through a Mechanism of Selectively Altered PRC2 Catalytic Activity, to Increase H3k27 Trimethylation","volume":"117","author":"Yap","year":"2011","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2000.00615.x","article-title":"Rel\/NF-\u03bab Transcription Factors: Key Mediators of B-cell Activation","volume":"176","author":"Pohl","year":"2000","journal-title":"Immunol Rev"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive Nuclear Factor \u03bab Activity is Required for Survival of Activated B Cell\u2013Like Diffuse Large B Cell Lymphoma Cells","volume":"194","author":"Davis","year":"2001","journal-title":"J Exp Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/nature07968","article-title":"Mutations of Multiple Genes Cause Deregulation of NF-\u03bab in Diffuse Large B-cell Lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/nature09671","article-title":"Oncogenically Active Myd88 Mutations in Human Lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2012.27.4.369","article-title":"Treatment of Diffuse Large B Cell Lymphoma","volume":"27","author":"Kwak","year":"2012","journal-title":"Korean J Intern Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a Standard Regimen (Chop) With Three Intensive Chemotherapy Regimens for Advanced non-Hodgkin\u2019s Lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008361513544","article-title":"Dose-Escalation Study of CHOP With or Without Prophylactic G-CSF in Aggressive non-Hodgkin\u2019s Lymphoma","volume":"11","author":"Itoh","year":"2000","journal-title":"Ann Oncol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1110","article-title":"From the Bench to the Bedside: Ways to Improve Rituximab Efficacy","volume":"104","author":"Cartron","year":"2004","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe D\u2019etude Des Lymphomes De L\u2019adulte","volume":"23","author":"Feugier","year":"2005","journal-title":"J Clin Oncol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2018.19.5.1181","article-title":"Clinical Response to CHOP vs. R-CHOP in Adult Patients With Diffuse Large B-Cell Lymphomas","volume":"19","author":"Tariq","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-Term Outcome of Patients in the LNH-98.5 Trial, the First Randomized Study Comparing rituximab-CHOP to Standard Chop Chemotherapy in DLBCL Patients: A Study by the Groupe D\u2019etudes Des Lymphomes De L\u2019adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795","article-title":"Chop Chemotherapy Plus Rituximab Compared With Chop Alone in Elderly Patients With Diffuse Large-B-Cell Lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30935-5","article-title":"Gene-Expression Profiling of Bortezomib Added to Standard Chemoimmunotherapy for Diffuse Large B-cell Lymphoma (Remodl-B): An Open-Label, Randomised, Phase 3 Trial","volume":"20","author":"Davies","year":"2019","journal-title":"Lancet Oncol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.2784","article-title":"Randomized Phase Ii Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With non-Germinal Center B-Cell-Like Diffuse Large B-cell Lymphoma","volume":"35","author":"Leonard","year":"2017","journal-title":"J Clin Oncol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02403","article-title":"Randomized Phase Iii Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non\u2013Germinal Center B-Cell Diffuse Large B-Cell Lymphoma","volume":"37","author":"Younes","year":"2019","journal-title":"J Clin Oncol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01366","article-title":"Robust: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma","volume":"39","author":"Nowakowski","year":"2021","journal-title":"J Clin Oncol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/nri2524","article-title":"B Cells in HIV Infection and Disease","volume":"9","author":"Moir","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1126\/science.7690497","article-title":"Immunoglobulin VH3 Gene Products: Natural Ligands for HIV Gp120","volume":"261","author":"Berberian","year":"1993","journal-title":"Science"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.3931","article-title":"Hiv-1 Envelope Triggers Polyclonal Ig Class Switch Recombination Through a CD40-Independent Mechanism Involving BAFF and C-Type Lectin Receptors","volume":"176","author":"He","year":"2006","journal-title":"J Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0005427","article-title":"Cd27- B-cells Produce Class Switched and Somatically Hyper-Mutated Antibodies During Chronic Hiv-1 Infection","volume":"4","author":"Cagigi","year":"2009","journal-title":"PloS One"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.5.637","article-title":"B Cells of HIV-1-infected Patients Bind Virions Through CD21-Complement Interactions and Transmit Infectious Virus to Activated T Cells","volume":"192","author":"Moir","year":"2000","journal-title":"J Exp Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.17.8855-8863.2002","article-title":"Human Immunodeficiency Virus Type 1 Bound to B Cells: Relationship to Virus Replicating in CD4+ T Cells and Circulating in Plasma","volume":"76","author":"Malaspina","year":"2002","journal-title":"J Virol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.11.6968","article-title":"Role for CD21 in the Establishment of an Extracellular Hiv Reservoir in Lymphoid Tissues","volume":"178","author":"Ho","year":"2007","journal-title":"J Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154839","article-title":"Impact of ART on Dynamics of Growth Factors and Cytokines in Primary Hiv Infection","volume":"125","author":"Bordoni","year":"2020","journal-title":"Cytokine"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00429.x","article-title":"Hiv-Induced IL-6\/IL-10 Dysregulation of CD4 Cells is Associated With Defective B Cell Help and Autoantibody Formation Against Cd4 Cells","volume":"111","author":"Weimer","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-35478-1","article-title":"Hiv-1 Envelope Glycoproteins Induce the Production of TNF-\u03b1 and IL-10 in Human Monocytes by Activating Calcium Pathway","volume":"8","author":"Plan\u00e8s","year":"2018","journal-title":"Sci Rep"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26032","article-title":"Endocytosis of HIV-1 Activates Plasmacytoid Dendritic Cells Via Toll-like Receptor- Viral Rna Interactions","volume":"115","author":"Beignon","year":"2005","journal-title":"J Clin Invest"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(95)00098-4","article-title":"Cd40 Ligand Triggers Interleukin-6 Mediated B Cell Differentiation","volume":"20","author":"Urashima","year":"1996","journal-title":"Leuk Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/363464a0","article-title":"Membrane Tumour Necrosis Factor-\u03b1 is Involved in the Polyclonal B-Cell Activation Induced by HIV-infected Human T Cells","volume":"363","author":"MacChia","year":"1993","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198308253090803","article-title":"Abnormalities of B-Cell Activation and Immunoregulation in Patients With the Acquired Immunodeficiency Syndrome","volume":"309","author":"Lane","year":"1983","journal-title":"N Engl J Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/j.0300-9475.2004.01376.x","article-title":"Immunoglobulin Levels Amongst Persons With and Without Human Immunodeficiency Virus Type 1 Infection in Uganda and Norway","volume":"59","author":"Lugada","year":"2004","journal-title":"Scand J Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.5897\/JAHR2017.0421","article-title":"The Role of IgG, Iga and IgM as Immunological Markers of HIV\/AIDS Progression","volume":"9","author":"Onifade","year":"2017","journal-title":"J AIDS HIV Res"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002185","article-title":"T-Cell and B-cell Perturbations are Similar in ART-naive HIV-1 and HIV-1\/2 Dually Infected Patients","volume":"33","author":"H\u00f8nge","year":"2019","journal-title":"Aids"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115621","article-title":"Human Immunodeficiency Virus Infection Induces Both Polyclonal and Virus-Specific B Cell Activation","volume":"89","author":"Shirai","year":"1992","journal-title":"J Clin Invest"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.181347898","article-title":"Hiv-1 Induces Phenotypic and Functional Perturbations of B Cells in Chronically Infected Individuals","volume":"98","author":"Moir","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B117","doi-asserted-by":"publisher","first-page":"eaai8153","DOI":"10.1126\/sciimmunol.aai8153","article-title":"Low CD21 Expression Defines a Population of Recent Germinal Center Graduates Primed for Plasma Cell Differentiation","volume":"2","author":"Lau","year":"2017","journal-title":"Sci Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2001.5054","article-title":"Mechanism of Hypergammaglobulinemia by HIV Infection: Circulating Memory B-cell Reduction With Plasmacytosis","volume":"100","author":"Nagase","year":"2001","journal-title":"Clin Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199812000-00005","article-title":"Impairment of B-lymphocyte Differentiation Induced by Dual Triggering of the B-cell Antigen Receptor and CD40 in Advanced Hiv-1-Disease","volume":"12","author":"Conge","year":"1998","journal-title":"Aids"},{"key":"B120","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.138.11.3720","article-title":"Infection With the Human Immunodeficiency Virus (HIV) is Associated With an In Vivo Increase in B Lymphocyte Activation and Immaturity","volume":"138","author":"Mart\u00ednez-Maza","year":"1987","journal-title":"J Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.12.5965","article-title":"Deleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function","volume":"170","author":"Malaspina","year":"2003","journal-title":"J Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-017-0592-x","article-title":"Irreversible Phenotypic Perturbation and Functional Impairment of B Cells During Hiv-1 Infection","volume":"11","author":"Yan","year":"2017","journal-title":"Front Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11904-010-0066-0","article-title":"Revisiting Immune Exhaustion During Hiv Infection","volume":"8","author":"Khaitan","year":"2011","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12339","article-title":"Cd21-\/Low B Cells: A Snapshot of a Unique B Cell Subset in Health and Disease","volume":"82","author":"Thorarinsdottir","year":"2015","journal-title":"Scand J Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835bd1f0","article-title":"Decoupling Activation and Exhaustion of B Cells in Spontaneous Controllers of HIV Infection","volume":"27","author":"Sciaranghella","year":"2013","journal-title":"AIDS"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050879","article-title":"Expression of the Immunoregulatory Molecule FcRH4 Defines a Distinctive Tissue-Based Population of Memory B Cells","volume":"202","author":"Ehrhardt","year":"2005","journal-title":"J Exp Med"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-Associated B Cell Exhaustion in a Dysfunctional Memory B Cell Compartment in HIV-infected Viremic Individuals","volume":"205","author":"Moir","year":"2008","journal-title":"J Exp Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181124","article-title":"Widespread B Cell Perturbations in HIV-1 Infection Afflict Naive and Marginal Zone B Cells","volume":"216","author":"Liechti","year":"2019","journal-title":"J Exp Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200212150-00003","article-title":"Effect of Long-Term Highly Active Antiretroviral Therapy in Restoring Hiv-Induced Abnormal B-Lymphocyte Function","volume":"31","author":"Jacobson","year":"2002","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.2.233","article-title":"Hiv-1 Antigen\u2013specific and \u2013Nonspecific B Cell Responses are Sensitive to Combination Antiretroviral Therapy","volume":"188","author":"Morris","year":"1998","journal-title":"J Exp Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1086\/526789","article-title":"Normalization of B Cell Counts and Subpopulations After Antiretroviral Therapy in Chronic Hiv Disease","volume":"197","author":"Moir","year":"2008","journal-title":"J Infect Dis"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1089\/088922204773004941","article-title":"Selective CD27+ (Memory) B Cell Reduction and Characteristic B Cell Alteration in Drug-Naive and HAART-Treated Hiv Type 1-Infected Patients","volume":"20","author":"Chong","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000869","article-title":"Chronic HIV-1 Infection Induces B-Cell Dysfunction That is Incompletely Resolved by Long-Term Antiretroviral Therapy","volume":"71","author":"Abudulai","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601560","article-title":"Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women","volume":"198","author":"Tanko","year":"2017","journal-title":"J Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2017.04.003","article-title":"Human Immunodeficiency Virus (HIV) and Epstein-Barr Virus (Ebv) Related Lymphomas, Pathology View Point","volume":"34","author":"Linke-Serins\u00f6z","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.146","article-title":"Dysfunctional Epstein-Barr Virus (Ebv)-Specific Cd8+ T Lymphocytes and Increased Ebv Load in HIV-1 Infected Individuals Progressing to AIDS-related non-Hodgkin Lymphoma","volume":"98","author":"Van Baarle","year":"2001","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01394.x","article-title":"Cmv-IVIG for Prevention of Epstein Barr Virus Disease and Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant Recipients","volume":"6","author":"Green","year":"2006","journal-title":"Am J Transplant"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.14.4510","article-title":"Epstein-Barr Virus Receptor of Human B Lymphocytes is the C3d Receptor Cr2","volume":"81","author":"Fingeroth","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr Virus: 40 Years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.10591.1","article-title":"Recent Advances in Understanding Epstein-Barr Virus","volume":"6","author":"Luftig","year":"2017","journal-title":"F1000Research"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv114","article-title":"Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System Components","volume":"212","author":"Chijioke","year":"2015","journal-title":"J Infect Dis"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00123-X","article-title":"Epstein-Barr Virus Associated Lymphoproliferations in the AIDS Setting","volume":"37","author":"Ambinder","year":"2001","journal-title":"Eur J Cancer"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-180315","article-title":"Hiv-Associated Lymphomas and Gamma-Herpesviruses","volume":"113","author":"Carbone","year":"2009","journal-title":"Blood"},{"key":"B144","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.seminoncol.2014.12.030","article-title":"Epstein-Barr Virus\u2013Associated Lymphomas","volume":"42","author":"Grywalska","year":"2015","journal-title":"Semin Oncol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"20160271","DOI":"10.1098\/rstb.2016.0271","article-title":"Epstein\u2013Barr Virus-Associated Lymphomas","volume":"372","author":"Shannon-Lowe","year":"2017","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/jvi.01928-16","article-title":"Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model But are Not Essential","volume":"91","author":"Ma","year":"2017","journal-title":"J Virol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5438.300","article-title":"Mimicry of CD40 Signals by Epstein-Barr Virus LMP1 in B Lymphocyte Responses","volume":"286","author":"Uchida","year":"1999","journal-title":"Science"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.78.4.1800-1816.2004","article-title":"Nuclear Factor \u03bab-Dependent Activation of the Antiapoptotic Bfl-1 Gene by the Epstein-Barr Virus Latent Membrane Protein 1 and Activated Cd40 Receptor","volume":"78","author":"D\u2019Souza","year":"2004","journal-title":"J Virol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2019.02.009","article-title":"LMP1 and 2A Induce the Expression of Nrf2 Through Akt Signaling Pathway in Epstein-Barr Virus\u2013Transformed B Cells","volume":"12","author":"Yun","year":"2019","journal-title":"Transl Oncol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14243","article-title":"Epstein-Barr Virus Ebna2 Directs Doxorubicin Resistance of B Cell Lymphoma Through CCL3 and CCL4-mediated Activation of NF-\u03bab and Btk","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"B151","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and Burden of HCV Co-Infection in People Living With Hiv: A Global Systematic Review and Meta-Analysis","volume":"16","author":"Platt","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B152","doi-asserted-by":"publisher","first-page":"e0156384","DOI":"10.1371\/journal.pone.0156384","article-title":"In Situ Hepatitis C Ns3 Protein Detection Is Associated With High Grade Features in Hepatitis C-Associated B-Cell non-Hodgkin Lymphomas","volume":"11","author":"Canioni","year":"2016","journal-title":"PloS One"},{"key":"B153","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/QAD.0000000000002461","article-title":"Hepatitis C Virus or Hepatitis B Virus Coinfection and Lymphoma Risk in People Living With Hiv","volume":"34","author":"Besson","year":"2020","journal-title":"Aids"},{"key":"B154","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12026-010-8168-8","article-title":"Hiv-Associated Immune Dysfunction and Viral Infection: Role in the Pathogenesis of AIDS-related Lymphoma","volume":"48","author":"Epeldegui","year":"2010","journal-title":"Immunol Res"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02761998000300019","article-title":"Immune Dysfunction and the Pathogenesis of AIDS-associated non-Hodgkin\u2019s Lymphoma","volume":"93","author":"Mart\u00ednez-Maza","year":"1998","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.07.049","article-title":"Genome-Wide Translocation Sequencing Reveals Mechanisms of Chromosome Breaks and Rearrangements in B Cells","volume":"147","author":"Chiarle","year":"2011","journal-title":"Cell"},{"key":"B157","doi-asserted-by":"publisher","first-page":"e11448","DOI":"10.1371\/journal.pone.0011448","article-title":"Cd40 Ligand (Cd154) Incorporated Into HIV Virions Induces Activation-Induced Cytidine Deaminase (Aid) Expression in Human B Lymphocytes","volume":"5","author":"Epeldegui","year":"2010","journal-title":"PloS One"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.7.1843.bloodjournal8571843","article-title":"Elevated Serum Levels of Soluble CD23 (Scd23) Precede the Appearance Ofacquired Immunodeficiency Syndrome\u2013Associated non-Hodgkin\u2019s Lymphoma","volume":"85","author":"Yawetz","year":"1995","journal-title":"Blood"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-13-0714","article-title":"Serum Levels of Cytokines and Biomarkers for Inflammation and Immune Activation, and HIV-Associated non-Hodgkin B-Cell Lymphoma Risk","volume":"23","author":"Vendrame","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.438895","article-title":"Exosomes Derived From HIV-1-infected Cells Contain Trans-Activation Response Element Rna","volume":"288","author":"Narayanan","year":"2013","journal-title":"J Biol Chem"},{"key":"B161","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1038\/s41467-018-07006-2","article-title":"Exosomes Derived From HIV-1-infected Cells Promote Growth and Progression of Cancer Via HIV Tar Rna","volume":"9","author":"Chen","year":"2018","journal-title":"Nat Commun"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030760","article-title":"Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and Mir-21","volume":"9","author":"Hern\u00e1ndez-Walias","year":"2020","journal-title":"J Clin Med"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-681411","article-title":"A Lymphomagenic Role for HIV Beyond Immune Suppression","volume":"127","author":"Dolcetti","year":"2016","journal-title":"Blood"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-06848-y","article-title":"A Single Amino Acid Substitution Confers B-Cell Clonogenic Activity to the HIV-1 Matrix Protein P17","volume":"7","author":"Giagulli","year":"2017","journal-title":"Sci Rep"},{"key":"B165","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbagen.2018.09.016","article-title":"Identification of Amino Acid Residues Critical for the B Cell Growth-Promoting Activity of HIV-1 Matrix Protein p17 Variants","volume":"1863","author":"He","year":"2019","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1206605109","article-title":"Hiv-1 Matrix Protein P17 Promotes Angiogenesis Via Chemokine Receptors CXCR1 and CXCR2","volume":"109","author":"Caccuri","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.1.275.413a30_275_282","article-title":"Expression of the Human Immunodeficiency Virus-Tat Gene in Lymphoid Tissues of Transgenic Mice Is Associated With B-Cell Lymphoma","volume":"94","author":"Kundu","year":"1999","journal-title":"Blood"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200103090-00001","article-title":"The HIV-1 Transactivator Protein Tat is a Potent Inducer of the Human Dna Repair Enzyme \u03b2-Polymerase","volume":"15","author":"Srivastava","year":"2001","journal-title":"Aids"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.1.344-353.2000","article-title":"Identification of Specific Molecular Structures of Human Immunodeficiency Virus Type 1 Tat Relevant for Its Biological Effects on Vascular Endothelial Cells","volume":"74","author":"Mitola","year":"2000","journal-title":"J Virol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3144","article-title":"Hiv-1 Vpr Induces DNA Double-Strand Breaks","volume":"66","author":"Tachiwana","year":"2006","journal-title":"Cancer Res"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.78.9.4408-4420.2004","article-title":"Human Immunodeficiency Virus (Hiv) Type 1 Vpu Induces the Expression of CD40 in Endothelial Cells and Regulates Hiv-Induced Adhesion of B-Lymphoma Cells","volume":"78","author":"Henderson","year":"2004","journal-title":"J Virol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.5450","article-title":"Immunophenotypic Analysis of AIDS-Related Diffuse Large B-Cell Lymphoma and Clinical Implications in Patients From AIDS Malignancies Consortium Clinical Trials 010 and 034","volume":"27","author":"Chadburn","year":"2009","journal-title":"J Clin Oncol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-116437","article-title":"Cell-of-Origin Identification and Prognostic Correlation in HIV-Associated Diffuse Large B-Cell Lymphomas: Results of an Italian Multicentric Study","volume":"132","author":"Rusconi","year":"2018","journal-title":"Blood"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.17.9809","article-title":"Tcl1 Oncogene Expression in AIDS-related Lymphomas and Lymphoid Tissues","volume":"96","author":"Teitell","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.2.122","article-title":"Differential Gene Expression in HIV\/SIV-associated and Spontaneous Lymphomas","volume":"2","author":"Nenasheva","year":"2005","journal-title":"Int J Med Sci"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-0506-3","article-title":"Identifying Transcriptional Profiles and Evaluating Prognostic Biomarkers of HIV-associated Diffuse Large B-Cell Lymphoma From Malawi","volume":"2","author":"Fedoriw","year":"2020","journal-title":"Mod Pathol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32381","article-title":"Enhanced DNA Repair and Genomic Stability Identify a Novel HIV-Related Diffuse Large B-cell Lymphoma Signature","volume":"145","author":"Maguire","year":"2019","journal-title":"Int J Cancer"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2020.02.007","article-title":"Diffuse Large B-Cell Lymphoma in a South African Cohort With a High Hiv Prevalence: An Analysis by Cell-of-Origin, Epstein\u2013Barr Virus Infection and Survival","volume":"145","author":"Cassim","year":"2020","journal-title":"Pathology"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2083","article-title":"Said J. A Comparative Study of Molecular Characteristics of Diffuse Large B-cell Lymphoma From Patients With and Without Human Immunodeficiency Virus Infection","volume":"21","author":"Chao","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/S1413-8670(12)70278-7","article-title":"Expression of Immunohistochemical Markers in Patients With AIDS-related Lymphoma","volume":"16","author":"Barreto","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800493","article-title":"AIDS and non-AIDS Diffuse Large B-cell Lymphomas Express Different Antigen Profiles","volume":"19","author":"Madan","year":"2006","journal-title":"Mod Pathol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020781","article-title":"Overexpression of Micrornas From the Mir-17-92 Paralog Clusters in AIDS-related non-Hodgkin\u2019s Lymphomas","volume":"6","author":"Thapa","year":"2011","journal-title":"PloS One"},{"key":"B183","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2161-1041.1000143","article-title":"MicroRNA 21 Expression Levels in HIV Negative and HIV Positive Diffuse Large B Cell Lymphoma","volume":"4","author":"Mcgrath E","year":"2015","journal-title":"Hered Genet"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000146","article-title":"Serum MicroRNAs in HIV-Infected Individuals as Pre-Diagnosis Biomarkers for AIDS-NHL","volume":"66","author":"Thapa","year":"2014","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07943.x","article-title":"Genome Wide DNA-Profiling of HIV-related B-Cell Lymphomas","volume":"148","author":"Capello","year":"2010","journal-title":"Br J Haematol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.813499","article-title":"Molecular Characteristics of Diffuse Large B-cell Lymphoma in Human Immunodeficiency Virus-Infected and -Uninfected Patients in the Pre-Highly Active Antiretroviral Therapy and Pre-Rituximab Era","volume":"55","author":"Morton","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"B187","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/QAI.0b013e3181d3d9eb","article-title":"Recurrent Chromosomal Alterations in Molecularly Classified AIDS-related Lymphomas: An Integrated Analysis of DNA Copy Number and Gene Expression","volume":"54","author":"Deffenbacher","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12705","article-title":"Molecular Analysis of Immunoglobulin Variable Genes in Human Immunodeficiency Virus-Related non-Hodgkin\u2019s Lymphoma Reveals Implications for Disease Pathogenesis and Histogenesis","volume":"93","author":"Capello","year":"2008","journal-title":"Haematologica"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1999.4782","article-title":"Aberrant Expression of CD27 and Soluble Cd27 (sCD27) in HIV Infection and in AIDS-associated Lymphoma","volume":"93","author":"Widney","year":"1999","journal-title":"Clin Immunol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-4800(03)00007-8","article-title":"Gene Expression Patterns in AIDS Versus non-AIDS-Related Diffuse Large B-cell Lymphoma","volume":"74","author":"Patrone","year":"2003","journal-title":"Exp Mol Pathol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.27610","article-title":"Clinical Significance of BCL2 , C- MYC , and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell\/non-Germinal Center B-Cell Subtypes, Co-Expression of MYC\/BCL2 Proteins and Co-expression of MYC\/BCL2\/BCL","volume":"16","author":"Ting","year":"2019","journal-title":"Int J Med Sci"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-460063","article-title":"Myc\/Bcl2 Protein Coexpression Contributes to the Inferior Survival of Activated B-Cell Subtype of Diffuse Large B-cell Lymphoma and Demonstrates High-Risk Gene Expression Signatures: A Report From the International Dlbcl Rituximab-Chop Consortium Program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002653","article-title":"Frequent Expression of Activation-Induced Cytidine Deaminase in Diffuse Large B-cell Lymphoma Tissues From Persons Living With Hiv","volume":"34","author":"Shponka","year":"2020","journal-title":"AIDS"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16176","article-title":"In Situ Bcl2 Expression is an Independent Prognostic Factor in HIV-associated DLBCL, a LYMPHOVIR Cohort Study","volume":"188","author":"Philippe","year":"2020","journal-title":"Br J Haematol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.744","article-title":"Expression Profile of MUM1\/IRF4, Bcl-6, and CD138\/syndecan-1 Defines Novel Histogenetic Subsets of Human Immunodeficiency Virus\u2013Related Lymphomas","volume":"97","author":"Carbone","year":"2001","journal-title":"Blood"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4631","article-title":"Aids-Related B-cell Lymphoma (Arl): Correlation of Prognosis With Differentiation Profiles Assessed by Immunophenotyping","volume":"106","author":"Hoffmann","year":"2005","journal-title":"Blood"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29969","article-title":"Soluble B-cell Activation Marker of sCD27 and sCD30 and Future Risk of B-cell Lymphomas: A Nested Case-Control Study and Meta-Analyses","volume":"138","author":"Hosnijeh","year":"2016","journal-title":"Int J Cancer"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000624","article-title":"Hiv-Infection Impact on Clinical-Biological Features and Outcome of Diffuse Large B-cell Lymphoma Treated With R-CHOP in the Combination Antiretroviral Therapy Era","volume":"29","author":"Baptista","year":"2015","journal-title":"Aids"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0186549","article-title":"Survival and Predictors of Death in People With HIV-associated Lymphoma Compared to Those With a Diagnosis of Lymphoma in General Population","volume":"12","author":"Cingolani","year":"2017","journal-title":"PloS One"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0595","article-title":"Hiv Infection and Survival of Lymphoma Patients in the Era of Highly Active Antiretroviral Therapy","volume":"26","author":"Han","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1086\/380129","article-title":"Outcome in Patients With Non-Hodgkin Lymphoma and With or Without Human Immunodeficiency Virus Infection","volume":"38","author":"Spina","year":"2004","journal-title":"Clin Infect Dis"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.8.2217","article-title":"Age and Serum Lactate Dehydrogenase Level are Independent Prognostic Factors in Human Immunodeficiency Virus-Related non-Hodgkin\u2019s Lymphomas: A Single-Institute Study of 96 Patients","volume":"14","author":"Vaccher","year":"1996","journal-title":"J Clin Oncol"},{"key":"B203","article-title":"The Prognosis of HIV-infected Patients With Diffuse Large B-Cell Lymphoma Treated With Chemotherapy and Highly Active Antiretroviral Therapy is Similar to That of HIV-negative Patients Receiving Chemotherapy","volume":"90","author":"Navarro","year":"2005","journal-title":"Haematologica"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated Cancer-Specific Mortality Among Hiv-Infected Patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J Clin Oncol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1310\/hct0803-132","article-title":"Improved Survival in HIV-Associated Diffuse Large B-Cell Lymphoma With the Addition of Rituximab to Chemotherapy in Patients Receiving Highly Active Antiretroviral Therapy","volume":"8","author":"Ezzat","year":"2007","journal-title":"HIV Clin Trials"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1437","article-title":"Rituximab Does Not Improve Clinical Outcome in a Randomized Phase 3 Trial of CHOP With or Without Rituximab in Patients With HIV-associated non-Hodgkin Lymphoma: Aids-Malignancies Consortium Trial 010","volume":"106","author":"Kaplan","year":"2005","journal-title":"Blood"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3300","article-title":"Rituximab Plus Infusional Cyclophosphamide, Doxorubicin, and Etoposide in HIV-associated non-Hodgkin Lymphoma: Pooled Results From 3 Phase 2 Trials","volume":"105","author":"Spina","year":"2005","journal-title":"Blood"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06943.x","article-title":"Safety and Efficacy of Cyclophosphamide, Adriamycin, Vincristine, Prednisone and Rituximab in Patients With Human Immunodeficiency Virus-Associated Diffuse Large B-Cell Lymphoma: Results of a Phase Ii Trial","volume":"140","author":"Ribera","year":"2008","journal-title":"Br J Haematol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.4684","article-title":"Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated non-Hodgkin\u2019s Lymphoma","volume":"24","author":"Bou\u00e9","year":"2006","journal-title":"J Clin Oncol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31802bb5d0","article-title":"Prognosis of AIDS-related Systemic non-Hodgkin Lymphoma Treated With Chemotherapy and Highly Active Antiretroviral Therapy Depends Exclusively on Tumor-Related Factors","volume":"44","author":"Miralles","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-231613","article-title":"Rituximab Plus Concurrent Infusional Epoch Chemotherapy is Highly Effective in HIV-associated B-Cell non-Hodgkin Lymphoma","volume":"115","author":"Sparano","year":"2010","journal-title":"Blood"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-373738","article-title":"How I Treat HIV-associated Lymphoma","volume":"119","author":"Dunleavy","year":"2012","journal-title":"Blood"},{"key":"B213","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3816\/CLM.2003.n.016","article-title":"Acquired Immunodeficiency Syndrome - Related Lymphoma in the Era of Highly Active Antiretroviral Therapy","volume":"4","author":"Thirlwell","year":"2003","journal-title":"Clin Lymphoma"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-253039","article-title":"The Role of Tumor Histogenesis, FDG-PET, and Short-Course Epoch With Dose-Dense Rituximab (Sc-EPOCH-RR) in HIV-associated Diffuse Large B-cell Lymphoma","volume":"115","author":"Dunleavy","year":"2010","journal-title":"Blood"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.301","article-title":"The Exclusion of People Living With Hiv (Plwh) From Clinical Trials in Lymphoma","volume":"113","author":"Venturelli","year":"2015","journal-title":"Br J Cancer"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-127505","article-title":"High Rate of Exclusion of HIV Infected Patients From Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials","volume":"134","author":"Menon","year":"2019","journal-title":"Blood"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.675353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T19:56:27Z","timestamp":1698954987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.675353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":216,"alternative-id":["10.3389\/fonc.2021.675353"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.675353","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"article-number":"675353"}}